Idenix Pharmaceuticals
Discovery and development of drugs for the treatment of human viral diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
$3.9b (Public information from Jun 2014)
Cambridge Massachusetts (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
* | N/A | - | |
| N/A | $140m | IPO | |
$20.0m | Late VC | ||
| N/A | $5.0m | Late VC | |
$107m | Post IPO Equity | ||
$3.9b Valuation: $3.9b | Acquisition | ||
| Total Funding | $25.0m | ||
Related Content
Recent News about Idenix Pharmaceuticals
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.